Works by Wasan, Harpreet

Results: 47
    1
    2
    3
    4
    5
    6

    Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.

    Published in:
    2018
    By:
    • Backen, Alison C.;
    • Lopes, Andre;
    • Wasan, Harpreet;
    • Palmer, Daniel H;
    • Duggan, Marian;
    • Cunningham, David;
    • Anthoney, Alan;
    • Corrie, Pippa G.;
    • Madhusudan, Srinivasan;
    • Maraveyas, Anthony;
    • Ross, Paul J.;
    • Waters, Justin S.;
    • Steward, William P.;
    • Rees, Charlotte;
    • McNamara, Mairéad G.;
    • Beare, Sandy;
    • Bridgewater, John A.;
    • Dive, Caroline;
    • Valle, Juan W.
    Publication type:
    journal article
    7
    8

    APC in the regulation of intestinal crypt fission.

    Published in:
    Journal of Pathology, 1998, v. 185, n. 3, p. 246, doi. 10.1002/(SICI)1096-9896(199807)185:3<246::AID-PATH90>3.0.CO;2-8
    By:
    • Wasan, Harpreet S.;
    • Park, Hyun-Sook;
    • Liu, Ken C.;
    • Mandir, Nirmala K.;
    • Winnett, Angela;
    • Sasieni, Peter;
    • Bodmer, Walter F.;
    • Goodlad, Robert A.;
    • Wright, Nicholas A.
    Publication type:
    Article
    9
    10
    11
    12

    ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.

    Published in:
    2016
    By:
    • Segelov, Eva;
    • Waring, Paul;
    • Desai, Jayesh;
    • Wilson, Kate;
    • Gebski, Val;
    • Thavaneswaran, Subotheni;
    • Elez, Elena;
    • Underhill, Craig;
    • Pavlakis, Nick;
    • Chantrill, Lorraine;
    • Nott, Louise;
    • Jefford, Michael;
    • Khasraw, Mustafa;
    • Day, Fiona;
    • Wasan, Harpreet;
    • Ciardiello, Fortunato;
    • Karapetis, Chris;
    • Joubert, Warren;
    • van Hazel, Guy;
    • Haydon, Andrew
    Publication type:
    journal article
    13

    Surgical Management of Patients with Neuroendocrine Neoplasms of the Appendix: Appendectomy or More.

    Published in:
    Neuroendocrinology, 2018, v. 106, n. 3, p. 242, doi. 10.1159/000478742
    By:
    • Pawa, Nikhil;
    • Clift, Ashley K.;
    • Osmani, Helai;
    • Drymousis, Panagiotis;
    • Cichocki, Andrzej;
    • Flora, Rashpal;
    • Goldin, Robert;
    • Patsouras, Dimitrios;
    • Baird, Alan;
    • Malczewska, Anna;
    • Kinross, James;
    • Faiz, Omar;
    • Antoniou, Anthony;
    • Wasan, Harpreet;
    • Kaltsas, Gregory A.;
    • Darzi, Ara;
    • Cwikla, Jaroslaw B.;
    • Frilling, Andrea
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 497, doi. 10.1186/1471-2407-14-497
    By:
    • Dutton, Susan J;
    • Kenealy, Nicola;
    • Love, Sharon B;
    • Wasan, Harpreet S;
    • Sharma, Ricky A;
    • FOXFIRE Protocol Development Group;
    • NCRI Colorectal Clinical Study Group
    Publication type:
    Article
    26

    FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer.

    Published in:
    2014
    By:
    • Dutton, Susan J;
    • Kenealy, Nicola;
    • Love, Sharon B;
    • Wasan, Harpreet S;
    • Sharma, Ricky A;
    • FOXFIRE Protocol Development Group and the NCRI Colorectal Clinical Study Group
    Publication type:
    journal article
    27

    Hormonal management of prostate cancer.

    Published in:
    Clinical Endocrinology, 1992, v. 37, n. 6, p. 477, doi. 10.1111/j.1365-2265.1992.tb01476.x
    By:
    • Wasan, Harpreet S.;
    • Waxman, Jonathan
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Clinical and molecular characterization of HER2 amplified-pancreatic cancer.

    Published in:
    Genome Medicine, 2013, v. 5, n. 8, p. 1, doi. 10.1186/gm482
    By:
    • Chou, Angela;
    • Waddell, Nicola;
    • Cowley, Mark J.;
    • Gill, Anthony J.;
    • Chang, David K.;
    • Patch, Ann-Marie;
    • Nones, Katia;
    • Wu, Jianmin;
    • Pinese, Mark;
    • Johns, Amber L.;
    • Miller, David K.;
    • Kassahn, Karin S.;
    • Nagrial, Adnan M.;
    • Wasan, Harpreet;
    • Goldstein, David;
    • Toon, Christopher W.;
    • Chin, Venessa;
    • Chantrill, Lorraine;
    • Humphris, Jeremy;
    • Scott Mead, R.
    Publication type:
    Article
    44

    Integration of Radiomicrosphere Therapy into the Contemporary Management Strategies for Primary and Metastatic Liver Cancer: Oncology Expert Opinions and Recommendations.

    Published in:
    Journal of Interventional Oncology, 2009, v. 2, n. 1, p. 46, doi. 10.2310/6650.2009.00007
    By:
    • Yuman Fong;
    • Wasan, Harpreet;
    • Leung, Thomas Wai-Tong;
    • Warner, Richard R. P.;
    • Pennington, Kenneth;
    • Kalayoglu, Munci;
    • Hall, Michael;
    • Rose, Steven C.;
    • Smith, Randall;
    • Liu, David M.;
    • Murthy, Ravi;
    • Kennedy, Andrew S.;
    • Nutting, Charlie;
    • Salem, Riad;
    • Gulec, Seza A.
    Publication type:
    Article
    45
    46
    47